{"id":{"repo_id":"missouri","oai_identifier":"oai:mospace.umsystem.edu:10355/9015"},"canonical_url":"https://search.dev.ndltd.org/etd/missouri/oai:mospace.umsystem.edu:10355/9015","repository":{"repo_id":"missouri","name":"University of Missouri","base_url":"https://mospace.umsystem.edu/oai/request"},"display":{"title":"The effects of exercise and omega-3 fatty acid supplementation as treatments for hepatic steatosis","abstract":"[ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI-COLUMBIA AT AUTHOR'S REQUEST.] The purpose of this study was to examine the individual and combined effects of exercise and dietary consumption of n3PUFAs as treatments for NAFLD. Otsuka Long-Evans Tokushima Fatty (OLETF) rats were studied due to their spontaneous development of obesity, insulin resistance, and NAFLD. A novelty of these rats is their intrinsic aptitude for voluntary wheel running despite their obesity. OLETFs were randomly divided into 4 groups (n=8/group): 1) remained sedentary 2) access to running wheels (3) diet supplemented with 3% of energy from fish oil and 4) access to running wheels and diet supplemented with 3% of energy from fish oil. Treatments began at 13 wk of age, an age when NAFLD is present in OLETF-SED rats, and lasted until all rats were sacrificed at 20 wk of age. Exercise appears to be more effective treatment for NAFLD in obese OLETF rats in part through increasing complete hepatic FAO, improving IS, and decreasing activation of the lipid synthesis pathway. Contrary to our original hypothesis, a diet moderately high in n3PUFAs failed to lower hepatic fat content and partially blunted the beneficial effects of exercise as a treatment strategy for NAFLD and systemic insulin resistance.","abstract_html":"[ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI-COLUMBIA AT AUTHOR'S REQUEST.] The purpose of this study was to examine the individual and combined effects of exercise and dietary consumption of n3PUFAs as treatments for NAFLD. Otsuka Long-Evans Tokushima Fatty (OLETF) rats were studied due to their spontaneous development of obesity, insulin resistance, and NAFLD. A novelty of these rats is their intrinsic aptitude for voluntary wheel running despite their obesity. OLETFs were randomly divided into 4 groups (n=8/group): 1) remained sedentary 2) access to running wheels (3) diet supplemented with 3% of energy from fish oil and 4) access to running wheels and diet supplemented with 3% of energy from fish oil. Treatments began at 13 wk of age, an age when NAFLD is present in OLETF-SED rats, and lasted until all rats were sacrificed at 20 wk of age. Exercise appears to be more effective treatment for NAFLD in obese OLETF rats in part through increasing complete hepatic FAO, improving IS, and decreasing activation of the lipid synthesis pathway. Contrary to our original hypothesis, a diet moderately high in n3PUFAs failed to lower hepatic fat content and partially blunted the beneficial effects of exercise as a treatment strategy for NAFLD and systemic insulin resistance.","abstract_has_math":false,"creators":["Borengasser, Sarah Jean, 1978-"],"institution":"University of Missouri--Columbia","degree_name":"Ph. D.","degree_level":"Doctoral","degree_discipline":"Nutrition area program (MU)","degree_department":null,"school":null,"contributors":[],"advisors":["Thyfault, John P."],"committee_chairs":[],"committee_members":[],"year":2010,"date_issued":"2010","date_published":"2010","updated_at":"2026-07-24T03:08:09Z","subjects":["hepatic steatosis","non-alcoholic fatty liver disease"],"languages":["eng","English"],"rights":["Access to files is limited to the University of Missouri--Columbia with SSO login."],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.doi","label":"DOI","values":["https://doi.org/10.32469/10355/9015"],"render_values":[{"text":"https://doi.org/10.32469/10355/9015","href":"https://doi.org/10.32469/10355/9015","code":true}]}]},"links":{"outbound_url":"https://hdl.handle.net/10355/9015","outbound_label":"Handle","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Thyfault, John P."]},{"key":"dc:creator","label":"Author","values":["Borengasser, Sarah Jean, 1978-"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2010-11-10T17:57:43Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2010-11-10T17:57:43Z"]},{"key":"dc:date.issued","label":"Date","values":["2010"]},{"key":"dc:publisher","label":"Institution","values":["University of Missouri--Columbia"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Nutrition area program (MU)"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Doctoral"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Ph. D."]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of Missouri--Columbia"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["hepatic steatosis","non-alcoholic fatty liver disease"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["English"]},{"key":"dc:language.iso","label":"Language (ISO)","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["Access to files is limited to the University of Missouri--Columbia with SSO login."]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.doi","label":"DOI","values":["https://doi.org/10.32469/10355/9015"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/10355/9015"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Title from PDF of title page (University of Missouri--Columbia, viewed on August 25, 2010).","The entire thesis text is included in the research.pdf file; the official abstract appears in the short.pdf file; a non-technical public abstract appears in the public.pdf file.","Dissertation advisor: Dr. John P. Thyfault.","Vita.","Ph. D. University of Missouri--Columbia 2010."]},{"key":"dc:description.abstract","label":"Abstract","values":["[ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI-COLUMBIA AT AUTHOR'S REQUEST.] The purpose of this study was to examine the individual and combined effects of exercise and dietary consumption of n3PUFAs as treatments for NAFLD. Otsuka Long-Evans Tokushima Fatty (OLETF) rats were studied due to their spontaneous development of obesity, insulin resistance, and NAFLD. A novelty of these rats is their intrinsic aptitude for voluntary wheel running despite their obesity. OLETFs were randomly divided into 4 groups (n=8/group): 1) remained sedentary 2) access to running wheels (3) diet supplemented with 3% of energy from fish oil and 4) access to running wheels and diet supplemented with 3% of energy from fish oil. Treatments began at 13 wk of age, an age when NAFLD is present in OLETF-SED rats, and lasted until all rats were sacrificed at 20 wk of age. Exercise appears to be more effective treatment for NAFLD in obese OLETF rats in part through increasing complete hepatic FAO, improving IS, and decreasing activation of the lipid synthesis pathway. Contrary to our original hypothesis, a diet moderately high in n3PUFAs failed to lower hepatic fat content and partially blunted the beneficial effects of exercise as a treatment strategy for NAFLD and systemic insulin resistance."]},{"key":"dc:title","label":"Title","values":["The effects of exercise and omega-3 fatty acid supplementation as treatments for hepatic steatosis"]}]}],"canonical_facts":{"dc:contributor.advisor":["Thyfault, John P."],"dc:creator":["Borengasser, Sarah Jean, 1978-"],"dc:date.accessioned":["2010-11-10T17:57:43Z"],"dc:date.available":["2010-11-10T17:57:43Z"],"dc:date.issued":["2010"],"dc:description":["Title from PDF of title page (University of Missouri--Columbia, viewed on August 25, 2010).","The entire thesis text is included in the research.pdf file; the official abstract appears in the short.pdf file; a non-technical public abstract appears in the public.pdf file.","Dissertation advisor: Dr. John P. Thyfault.","Vita.","Ph. D. University of Missouri--Columbia 2010."],"dc:description.abstract":["[ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI-COLUMBIA AT AUTHOR'S REQUEST.] The purpose of this study was to examine the individual and combined effects of exercise and dietary consumption of n3PUFAs as treatments for NAFLD. Otsuka Long-Evans Tokushima Fatty (OLETF) rats were studied due to their spontaneous development of obesity, insulin resistance, and NAFLD. A novelty of these rats is their intrinsic aptitude for voluntary wheel running despite their obesity. OLETFs were randomly divided into 4 groups (n=8/group): 1) remained sedentary 2) access to running wheels (3) diet supplemented with 3% of energy from fish oil and 4) access to running wheels and diet supplemented with 3% of energy from fish oil. Treatments began at 13 wk of age, an age when NAFLD is present in OLETF-SED rats, and lasted until all rats were sacrificed at 20 wk of age. Exercise appears to be more effective treatment for NAFLD in obese OLETF rats in part through increasing complete hepatic FAO, improving IS, and decreasing activation of the lipid synthesis pathway. Contrary to our original hypothesis, a diet moderately high in n3PUFAs failed to lower hepatic fat content and partially blunted the beneficial effects of exercise as a treatment strategy for NAFLD and systemic insulin resistance."],"dc:identifier.doi":["https://doi.org/10.32469/10355/9015"],"dc:identifier.uri":["https://hdl.handle.net/10355/9015"],"dc:language":["English"],"dc:language.iso":["eng"],"dc:publisher":["University of Missouri--Columbia"],"dc:rights":["Access to files is limited to the University of Missouri--Columbia with SSO login."],"dc:subject":["hepatic steatosis","non-alcoholic fatty liver disease"],"dc:title":["The effects of exercise and omega-3 fatty acid supplementation as treatments for hepatic steatosis"],"dc:type":["Thesis"],"thesis:degree_discipline":["Nutrition area program (MU)"],"thesis:degree_level":["Doctoral"],"thesis:degree_name":["Ph. D."],"thesis:institution_name":["University of Missouri--Columbia"]},"updated_at":"2026-07-24T03:08:09Z"}